CareFusion Corporation Hit With Another High-Risk Recall Over Alaris Infusion Pumps

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Alaris Pump Module (Model 8100), Version 9.1.18 Software by CareFusion 303, Inc: Class I Recall - May Not Properly Delay an Infusion

AUDIENCE: Risk Manager, Biomedical Engineer, Nursing

ISSUE: CareFusion is recalling the Alaris Pump model 8100, version 9.1.18, because the pump may have a software failure where the pump module will not properly delay an infusion when the Delay Until option or Multidose feature is used. This issue does not impact the Delay For Option. The software failure also causes the pump to not properly deliver a multidose infusion as expected under certain conditions. See the FDA recall notice for more information.

Infusion start times earlier or later than intended could result in serious injury or death.

BACKGROUND: The Alaris Pump Model 8100 is a large volume infusion pump. The affected products were manufactured from February 6, 2014 to April 8, 2014 and distributed from February 7, 2014 through April 7, 2014. See the FDA recall notice for a listing of the affected serial numbers.

RECOMMENDATION: The firm recommends that the previous Alaris Pump module software version 9.1.17 be installed to address this recall. CareFusion will contact all affected customers to schedule the installation of software version 9.1.17. Do NOT use the Alaris Pump module Delay Until option. Do NOT use the Multidose feature.

As an interim guidance, customers may update their dataset to disable both Delay Options and/or Multidose across all Profiles to prevent the use of Delay Until option and/or Multidose feature. These are shared configurations with the Alaris Syringe module and if disabled would prevent use of these features with the Alaris Syringe module as well.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC